Jeffrey A. Deiuliis

Jeffrey A. Deiuliis

Auto-generated profile, based on publicly available information

Jeffrey A. Deiuliis

Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2009 in Circulation
Verified
Journal Article
Open access
PDF file
QSQinghua Sun
Qinghua Sun
PYPeibin Yue
Peibin Yue
JDJeffrey A. Deiuliis
Jeffrey A. Deiuliis
CLCarey N. Lumeng
Carey N. Lumeng
TKThomas Kampfrath
Thomas Kampfrath
SRsanjay Rajagopalan
sanjay Rajagopalan
Background— There is a strong link between urbanization and type 2 diabetes mellitus. Although a multitude of mechanisms have been proposed, there are no studies evaluating the impact of ambient air pollutants and the propensity to develop type 2 diabetes mellitus. We hypothesized that exposure to ambient fine particulate matter (<2.5 μm; PM 2.5 ) exaggerates diet-induced insulin resistance, adipose inflammation, and visceral adiposity. Methods and Results— Male C57BL/6 mice were fed high-fat chow for 10 weeks and randomly assigned to concentrated ambient PM 2.5 or filtered air (n=14 per group) for 24 weeks. PM 2.5 -exposed C57BL/6 mice exhibited marked whole-body insulin resistance, systemic inflammation, and an increase in visceral adiposity. PM 2.5 exposure induced signaling abnormalities characteristic of insulin resistance, including decreased Akt and endothelial nitric oxide synthase phosphorylation in the endothelium and increased protein kinase C expression. These abnormalilties were associated with abnormalities in vascular relaxation to insulin and acetylcholine. PM 2.5 increased adipose tissue macrophages (F4/80 + cells) in visceral fat expressing higher levels of tumor necrosis factor-α/interleukin-6 and lower interleukin-10/ N -acetyl-galactosamine specific lectin 1. To test the impact of PM 2.5 in eliciting direct monocyte infiltration into fat, we rendered FVBN mice expressing yellow fluorescent protein (YFP) under control of a monocyte-specific promoter (c- fms , c- fms YFP ) diabetic over 10 weeks and then exposed these mice to PM 2.5 or saline intratracheally. PM 2.5 induced YFP cell accumulation in visceral fat and potentiated YFP cell adhesion in the microcirculation. Conclusion— PM 2.5 exposure exaggerates insulin resistance and visceral inflammation/adiposity. These findings provide a new link between air pollution and type 2 diabetes mellitus.

22 November 2011 in Circulation
Verified
Journal Article
Open access
PDF file
ZSZubair Shah
Zubair Shah
TKThomas Kampfrath
Thomas Kampfrath
JDJeffrey A. Deiuliis
Jeffrey A. Deiuliis
Jixing ZhongJixing Zhong
Jixing Zhong
CPColleen Pineda
Colleen Pineda
SRsanjay Rajagopalan
sanjay Rajagopalan
Background—: Dipeptidyl-peptidase 4 (DPP-4) inhibitors are increasingly used to accomplish glycemic targets in patients with type II diabetes mellitus. Because DPP-4 is expressed in inflammatory cells, we hypothesized that its inhibition will exert favorable effects in atherosclerosis.Methods and Results—: Male LDLR−/−mice (6 weeks) were fed a high-fat diet or normal chow diet for 4 weeks and then randomized to vehicle or alogliptin, a high-affinity DPP-4 inhibitor (40 mg · kg−1· d−1), for 12 weeks. Metabolic parameters, blood pressure, vascular function, atherosclerosis burden, and indexes of inflammation were obtained in target tissues, including the vasculature, adipose, and bone marrow, with assessment of global and cell-specific inflammatory pathways. In vitro and in vivo assays of DPP-4 inhibition (DPP-4i) on monocyte activation/migration were conducted in both human and murine cells and in a short-term ApoE−/−mouse model. DPP-4i improved markers of insulin resistance and reduced blood pressure. DPP-4i reduced visceral adipose tissue macrophage content (adipose tissue macrophages; CD11b+, CD11c+, Ly6Chi) concomitant with upregulation of CD163. DPP-4 was highly expressed in bone marrow–derived CD11b+cells, with DPP-4i downregulating proinflammatory genes in these cells. DPP-4i decreased aortic plaque with a striking reduction in plaque macrophages. DPP-4i prevented monocyte migration and actin polymerization in in vitro assays via Rac-dependent mechanisms and prevented in vivo migration of labeled monocytes to the aorta in response to exogenous tumor necrosis factor-α and DPP-4.Conclusion—: DPP-4i exerts antiatherosclerotic effects and reduces inflammation via inhibition of monocyte activation/chemotaxis. These findings have important implications for the use of this class of drugs in atherosclerosis.

27 August 2015 in International Journal of Obesity
Verified
Journal Article
Open access
JDJ A Deiuliis
J A Deiuliis
The prevalence of overweight and obesity in developed and developing countries has greatly increased the risk of insulin resistance and type 2 diabetes mellitus. It is evident from human and experimental animal studies that obesity alters microRNA (miRNA) expression in metabolically important organs, and that miRNAs are involved in changes in normal physiology acting as mediators of disease. miRNAs regulate multiple pathways including insulin signaling, immune-mediated inflammation, adipokine expression, adipogenesis, lipid metabolism, and food intake regulation. Thus, miRNA-based therapeutics represent an innovative and attractive treatment modality, with non-human primate studies showing great promise. In addition, miRNA measures in plasma or bodily fluids may be used as disease biomarkers and predictors of metabolic disease in humans. This review analyzes the role of miRNAs in obesity and insulin resistance, focusing on the miR-17/92, miR-143-145, miR-130, let-7, miR-221/222, miR-200, miR-223, miR-29, and miR-375 families, as well as miRNA changes by relevant tissue (adipose, liver, and skeletal muscle). Further, the current and future applications of miRNA-based therapeutics and diagnostics in metabolic disease are discussed.

18 March 2011 in Circulation Research
Verified
Journal Article
Closed access
PDF file
TKThomas Kampfrath
Thomas Kampfrath
AMAndrei Maiseyeu
Andrei Maiseyeu
ZYZhekang Ying
Zhekang Ying
ZSZubair Shah
Zubair Shah
JDJeffrey A. Deiuliis
Jeffrey A. Deiuliis
SRSanjay Rajagopalan
Sanjay Rajagopalan
Rationale:: Chronic exposure to ambient air-borne particulate matter of <2.5 μm (PM 2.5 ) increases cardiovascular risk. The mechanisms by which inhaled ambient particles are sensed and how these effects are systemically transduced remain elusive. Objective:: To investigate the molecular mechanisms by which PM 2.5 mediates inflammatory responses in a mouse model of chronic exposure. Methods and Results:: Here, we show that chronic exposure to ambient PM 2.5 promotes Ly6C high inflammatory monocyte egress from bone-marrow and mediates their entry into tissue niches where they generate reactive oxygen species via NADPH oxidase. Toll-like receptor (TLR)4 and Nox2 (gp91 phox ) deficiency prevented monocyte NADPH oxidase activation in response to PM 2.5 and was associated with restoration of systemic vascular dysfunction. TLR4 activation appeared to be a prerequisite for NAPDH oxidase activation as evidenced by reduced p47 phox phosphorylation in TLR4 deficient animals. PM 2.5 exposure markedly increased oxidized phospholipid derivatives of 1-palmitoyl-2-arachidonyl- sn -glycero-3-phosphorylcholine (oxPAPC) in bronchioalveolar lavage fluid. Correspondingly, exposure of bone marrow–derived macrophages to oxPAPC but not PAPC recapitulated effects of chronic PM 2.5 exposure, whereas TLR4 deficiency attenuated this response. Conclusions:: Taken together, our findings suggest that PM 2.5 triggers an increase in oxidized phospholipids in lungs that then mediates a systemic cellular inflammatory response through TLR4/NADPH oxidase–dependent mechanisms.

26 January 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JDJeffrey Deiuliis
Jeffrey Deiuliis
ZSZubair Shah
Zubair Shah
NSNilay Shah
Nilay Shah
BNBradley Needleman
Bradley Needleman
DMDean Mikami
Dean Mikami
SRSanjay Rajagopalan
Sanjay Rajagopalan
The development of insulin resistance (IR) in mouse models of obesity and type 2 diabetes mellitus (DM) is characterized by progressive accumulation of inflammatory macrophages and subpopulations of T cells in the visceral adipose. Regulatory T cells (Tregs) may play a critical role in modulating tissue inflammation via their interactions with both adaptive and innate immune mechanisms. We hypothesized that an imbalance in Tregs is a critical determinant of adipose inflammation and investigated the role of Tregs in IR/obesity through coordinated studies in mice and humans. Foxp3-green fluorescent protein (GFP) “knock-in” mice were randomized to a high-fat diet intervention for a duration of 12 weeks to induce DIO/IR. Morbidly obese humans without overt type 2 DM (n = 13) and lean controls (n = 7) were recruited prospectively for assessment of visceral adipose inflammation. DIO resulted in increased CD3+CD4+, and CD3+CD8+ cells in visceral adipose with a striking decrease in visceral adipose Tregs. Treg numbers in visceral adipose inversely correlated with CD11b+CD11c+ adipose tissue macrophages (ATMs). Splenic Treg numbers were increased with up-regulation of homing receptors CXCR3 and CCR7 and marker of activation CD44. In-vitro differentiation assays showed an inhibition of Treg differentiation in response to conditioned media from inflammatory macrophages. Human visceral adipose in morbid obesity was characterized by an increase in CD11c+ ATMs and a decrease in foxp3 expression. Our experiments indicate that obesity in mice and humans results in adipose Treg depletion. These changes appear to occur via reduced local differentiation rather than impaired homing. Our findings implicate a role for Tregs as determinants of adipose inflammation.

13 December 2012 in Diabetes
Verified
Journal Article
Open access
PDF file
Jixing ZhongJixing Zhong
Jixing Zhong
XRXiaoquan Rao
Xiaoquan Rao
JDJeffrey Deiuliis
Jeffrey Deiuliis
ZBZachary Braunstein
Zachary Braunstein
VNVimal Narula
Vimal Narula
SRsanjay Rajagopalan
sanjay Rajagopalan
Dipeptidyl peptidase-4 (DDP4) inhibitors target the enzymatic degradation of incretin peptides and represent a major advance in the treatment of type 2 diabetes. DPP4 has a number of nonenzymatic functions that involve its interaction with adenosine deaminase (ADA) and other extracellular matrix proteins. Here, we assessed the nonenzymatic role of DPP4 in regulating dendritic cell (DC)/macrophage–mediated adipose inflammation in obesity. Both obese humans and rodents demonstrated increased levels of DPP4 expression in DC/macrophage cell populations from visceral adipose tissue (VAT). The DPP4 expression increased during monocyte differentiation to DC/macrophages and with lipopolysaccharide (LPS)-induced activation of DC/macrophages. The DPP4 colocalized with membrane-bound ADA on human DCs and enhanced the ability of the latter to stimulate T-cell proliferation. The DPP4 interaction with ADA in human DC/macrophages was competitively inhibited by the addition of exogenous soluble DPP4. Knockdown of DPP4 in human DCs, but not pharmacologic inhibition of their enzymatic function, significantly attenuated the ability to activate T cells without influencing its capacity to secrete proinflammatory cytokines. The nonenzymatic function of DPP4 on DC may play a role in potentiation of inflammation in obesity by interacting with ADA. These findings suggest a novel role for the paracrine regulation of inflammation in adipose tissue by DPP4.